Find Therapeutics Inc., a US-based biopharmaceutical company, announced on Monday that it has named Paul F Truex as its new director effective 1 August 2022.
Presently, Truex is the chairman and CEO of Thryv Therapeutics (formerly LQT Therapeutics, Laval, Quebec). He has three decades of experience in the pharmaceutical industry, including having founded and headed several successful biotech companies while serving on multiple boards. He has participated in various IPOs including Milestone (board member), Trius (board member), Anthera (CEO), Peninsula (CEO), and Versicor (VP).
Philippe Douville, Find Therapeutics chief executive officer, said, 'On behalf of the board of directors, it is a pleasure to welcome Paul to our team. Paul's long history of successful leadership, coupled with his extensive network in the life sciences ecosystem makes him an ideal person for this role. I look forward to working closely with Paul as we continue to advance our programs.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer